You are here: Home
Categories

Prostate specific antigen:

1. Prostate Cancer Diagnosis
...  With advanced disease, hematuria, obstructive symptoms and bone pain from metastases can be present.  It is less common to diagnosis advanced disease due to sceening with prostate specific antigen ...
2. Treatment for Localized Prostate Cancer
... Fine J: Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation. J Urol  2004; 171:2221-2225. ...
3. Prostate Cancer Grading & Staging Systems
... tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. J Urol  2008; 179(6):2187-2191. Helo et al, 2009. ...
4. Prostate Cancer Screening
... WJ, Bartsch G, Rittenhouse HG, Evans CL, Linton HJ, Horninger W, Klocker H, Mikolajczyk SD.Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml ...
5. Prostate Cancer: Prevalence - Incidence - Mortality
... in men and the second leading cause of cancer related deaths in men. The detection and treatment of this condition has been revolutionized by the introduction of serum prostate specific antigen [PSA] ...
6. Beyond the Abstract - Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer, by G. Steven Bova, MD
BERKELEY, CA (UroToday.com) - I was trained and board certified as a urologist (University of Virginia) and pathologist (Cornell and UVA)
7. Beyond the Abstract - The role of biopsy core number in selecting prostate cancer patients for active surveillance, by Guillaume Ploussard, MD and Alexandre de la Taille, MD
BERKELEY, CA (UroToday.com) - Active surveillance (AS) entails a strategy by which selected men are managed expectantly with the intention of applying potentially curative treatment in case of signs of ...
8. Beyond the Abstract - Anxiety and distress during active surveillance for early prostate cancer, by Roderick C.N. van den Bergh, MD, et al.
BERKELEY, CA (UroToday.com) - The present study found that the majority of men with early prostate cancer (PC) included in a protocol-based program for active surveillance (AS) show favorable anxiety and ...
9. Beyond the Abstract - DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme, by Sumit Isharwal, MD, et
BERKELEY, CA (UroToday.com) - The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
10. Beyond the Abstract - Dose-escalation using intensity-modulated radiotherapy for prostate cancer - Evaluation of the dose distribution with and without (18)F-choline PET-CT detected simultaneous integrated boost, by Michael Pinkawa, MD
BERKELEY, CA (UroToday.com) - Randomized three-dimensional conformal radiotherapy dose escalation studies have consistently shown improved biochemical control rates for prostate cancer.
11. Beyond the Abstract - Predictive implications of bone turnover markers after palliative treatment with (186)Re-HEDP in hormone-refractory prostate cancer patients with painful osseous metastases, by Athanasios Zafeirakis, MD, PhD
BERKELEY, CA (UroToday.com) - Bone is a very common site of prostate cancer metastases, and in most patients the only site of disease progression.
12. Beyond the Abstract - Rectal morbidity after permanent interstitial brachytherapy for prostate cancer-Impact of day 1 vs. day 30 computed tomography-based postimplant dosimetry, by Michael Pinkawa, MD
BERKELEY, CA (UroToday.com) - Rectal morbidity is a serious concern following prostate brachytherapy due to the proximity of the prostate and rectal wall. I
13. Beyond the Abstract - Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: A prospective comparative toxicity analysis, by Marc Gaudet, MD, et al.
BERKELEY, CA (UroToday.com) - Treatment volume definitions for permanent implant brachytherapy have evolved over the past 25 years, but treatment volume still encompasses the entire prostate without more ...
14. Beyond the Abstract - Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity,
BERKELEY, CA (UroToday.com) - When thinking of hormonal influences on the prostate, few clinicians would immediately list prolactin among the significant.
15. Beyond the Abstract - Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden, by Melissa Thong, PhD, et al.
BERKELEY, CA (UroToday.com) - Men diagnosed with low-risk localised prostate cancer often face the difficulty of choosing an appropriate treatment.
16. Beyond the Abstract - Agents targeting prostate cancer bone metastasis, by Khalid S. Mohammad, MD, PhD, and John M. Chirgwin, PhD
BERKELEY, CA (UroToday.com) - Advanced prostate cancers regularly metastasize to the skeleton, and better treatments are needed to decrease morbidity and increase survival in men with end-stage disease. ...
17. Beyond the Abstract - Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study, by Roderick van den Bergh, MD, et al.
BERKELEY, CA (UroToday.com) - Screening for prostate cancer has the potential of decreasing the number of deaths due to this disease, but also knocks the lid off Pandora’s box.
18. Beyond the Abstract - Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis, by Evan Y. Yu, MD and Eva Corey, PhD
BERKELEY, CA (UroToday.com) - In our preclinical evaluation of dasatinib, a small molecular kinase inhibitor of Src family kinases (SFK), we used a model of growth of C4-2B prostate cancer cells in the ...
19. Beyond the Abstract - Prostate cancer: A newly discovered route for testosterone to reach the prostate: Treatment by super-selective intraprostatic androgen deprivation, by Y. Gat, MSc, MD, PhD, and M. Gornish, MD
BERKELEY, CA (UroToday.com) - Varicocele has only recently been shown to be a bilateral disease, the primary cause for male infertility and low testosterone level.
20. Beyond the Abstract - Rethinking screening for breast cancer and prostate cancer, by Laura Esserman, MD, MBA and Ian Thompson, MD
BERKELEY, CA (UroToday.com) - As cancer surgeons, we witness the fear and anxiety we create when we tell patients that they may have cancer.